Globe Life (NYSE:GL) Earns “Outperform” Rating from Keefe, Bruyette & Woods

Globe Life (NYSE:GL)‘s stock had its “outperform” rating restated by analysts at Keefe, Bruyette & Woods in a note issued to investors on Thursday,Benzinga reports. They presently have a $168.00 price target on the stock. Keefe, Bruyette & Woods’ target price would suggest a potential upside of 21.93% from the stock’s previous close.

A number of other brokerages have also recently issued reports on GL. Wells Fargo & Company boosted their target price on Globe Life from $170.00 to $171.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Truist Financial boosted their price objective on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research note on Friday, February 6th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Finally, Evercore set a $157.00 target price on shares of Globe Life in a research note on Wednesday, February 18th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and an average price target of $172.00.

Globe Life Trading Up 0.2%

Shares of GL traded up $0.28 during trading hours on Thursday, hitting $137.79. The stock had a trading volume of 90,314 shares, compared to its average volume of 495,341. Globe Life has a 12-month low of $109.38 and a 12-month high of $152.71. The firm has a market cap of $10.81 billion, a P/E ratio of 9.80 and a beta of 0.46. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.07 and a current ratio of 0.07. The company’s fifty day simple moving average is $141.54 and its 200 day simple moving average is $138.89.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. Globe Life’s revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts forecast that Globe Life will post 13.87 EPS for the current fiscal year.

Insider Buying and Selling

In other news, EVP Robert Edward Hensley sold 712 shares of Globe Life stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total transaction of $101,524.08. Following the sale, the executive vice president owned 8,580 shares in the company, valued at $1,223,422.20. This trade represents a 7.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO James Matthew Darden sold 18,318 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the transaction, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. The trade was a 26.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 82,807 shares of company stock valued at $12,041,286 over the last three months. Company insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

Several large investors have recently modified their holdings of the business. Norges Bank bought a new position in Globe Life during the second quarter worth $157,722,000. Northwestern Mutual Wealth Management Co. increased its stake in Globe Life by 34,786.0% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 881,919 shares of the company’s stock valued at $123,345,000 after purchasing an additional 879,391 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock worth $174,340,000 after purchasing an additional 696,548 shares during the period. Balyasny Asset Management L.P. bought a new position in shares of Globe Life in the 3rd quarter worth about $80,925,000. Finally, Westfield Capital Management Co. LP bought a new position in shares of Globe Life in the 3rd quarter worth about $61,569,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.